Other
Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain.
JAMA · 9 Oct 2026
Record
Publication details
- Authors
- Rubin R
- Journal
- JAMA
- Publication date
- 9 Oct 2026
- Publication type
- Journal Article
- Evidence type
- Other
- Relevance classification
- Primary
- PubMed ID
- 42853576
- DOI
- 10.1001/jama.2026.20514
- Language
- eng
- Linked clinical trial
- Not reported
Abstract
This Medical News article discusses the reasons behind the burgeoning black market for 2 unapproved GLP-1 weight loss drugs and the potential risks associated with their use.
Weekly briefing
The Retatrutide Report
The most important retatrutide clinical trial, research and regulatory developments, once a week.
No spam. Unsubscribe anytime. By subscribing, you agree to receive the Retatrutide Report by email. You can unsubscribe at any time. Privacy Policy.